Angiotensin II Infusion in apoE Wild-type Mice
Objective: To determine whether angiotensin II infusion alone can generate aneurysms in apoE wild-type mice, and to establish that hyperlipidemia is required for aneurysm formation when combined with angiotensin II
This is a Angiotensin II Infusion in apoE Wild-type Mice protocol using mouse as the model organism. The procedure involves 6 procedural steps, 1 equipment items, 2 materials. Extracted from a 2000 paper published in Journal of Clinical Investigation.
Model and subjects
mouse • apoE wild-type (apoE+/+) • unknown • mature • not specified
Study window
Estimated timing pending
Core workflow
Osmotic minipump implantation • Measurement of arterial blood pressure • Body weight monitoring
Primary readouts
- Presence or absence of abdominal aortic aneurysms
- Severity of aortic atherosclerotic lesions
- Arterial blood pressure changes
- Body weight changes
Key equipment and reagents
Use this page as an execution guide, then fall back to the source paper whenever you need exact exclusions, dosing details, or assay-specific caveats.
Confirm first
- Verify the animal model, intervention setup, and collection timepoints against the source paper.
- Check that every direct vendor link matches the exact specification your lab plans to run.
Use the page like this
- Work through the protocol steps in order and use the inline vendor chips only when you need to source or verify an item.
- Jump to Experimental Context for readouts, data shape, and analysis flow before planning downstream analysis.
Protocol Steps
Start here. The step list is optimized for running the experiment, with direct vendor links available inline when you need to source a cited item.
Osmotic minipump implantation
Implant osmotic minipumps containing either angiotensin II or vehicle control into mature apoE wild-type mice
Note: Pumps deliver continuous infusion over the entire month-long experimental period
View evidence from paper
“we infused Ang II or vehicle for 1 month via osmotic minipumps into mature apoE +/+ mice”
Measurement of arterial blood pressure
Monitor arterial blood pressure throughout the infusion period to assess hemodynamic effects
Note: These doses of Ang II did not alter arterial blood pressure in apoE+/+ mice
View evidence from paper
“These doses of Ang II did not alter arterial blood pressure, body weight, serum cholesterol concentrations”
Body weight monitoring
Track body weight changes throughout the infusion period
Note: Ang II infusion did not alter body weight in apoE+/+ mice
View evidence from paper
“These doses of Ang II did not alter arterial blood pressure, body weight, serum cholesterol concentrations”
Serum cholesterol measurement
Measure serum cholesterol concentrations and distribution of lipoprotein cholesterol
Note: Ang II did not alter serum cholesterol or lipoprotein cholesterol distribution in apoE+/+ mice
View evidence from paper
“These doses of Ang II did not alter arterial blood pressure, body weight, serum cholesterol concentrations, or distribution of lipoprotein cholesterol”
Tissue collection and examination
Collect aortic tissue and examine for atherosclerotic lesions and aneurysms
Note: Examine for presence or absence of abdominal aortic aneurysms and atherosclerotic lesions
View evidence from paper
“infusions of Ang II into apoE +/+ mice failed to generate aneurysms”
Sequential sectioning of aortic tissue
Perform sequential sectioning of abdominal aorta to characterize any structural changes
Note: Examine for medial breaks, adventitial remodeling, and dilation
View evidence from paper
“Sequential sectioning of aneurysmal abdominal aorta revealed two major characteristics: an intact artery that is surrounded by a large remodeled adventitia”